ROCK inhibitors for the treatment of ocular diseases

Article Properties
Abstract
Cite
Nourinia, Ramin, et al. “ROCK Inhibitors for the Treatment of Ocular Diseases”. British Journal of Ophthalmology, vol. 102, no. 1, 2017, pp. 1-5, https://doi.org/10.1136/bjophthalmol-2017-310378.
Nourinia, R., Nakao, S., Zandi, S., Safi, S., Hafezi-Moghadam, A., & Ahmadieh, H. (2017). ROCK inhibitors for the treatment of ocular diseases. British Journal of Ophthalmology, 102(1), 1-5. https://doi.org/10.1136/bjophthalmol-2017-310378
Nourinia, Ramin, Shintaro Nakao, Souska Zandi, Sare Safi, Ali Hafezi-Moghadam, and Hamid Ahmadieh. “ROCK Inhibitors for the Treatment of Ocular Diseases”. British Journal of Ophthalmology 102, no. 1 (2017): 1-5. https://doi.org/10.1136/bjophthalmol-2017-310378.
Nourinia R, Nakao S, Zandi S, Safi S, Hafezi-Moghadam A, Ahmadieh H. ROCK inhibitors for the treatment of ocular diseases. British Journal of Ophthalmology. 2017;102(1):1-5.
Journal Categories
Medicine
Medicine
Medicine (General)
Medicine
Ophthalmology
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
One‐year clinical evaluation of 0.4% ripasudil (K‐115) in patients with open‐angle glaucoma and ocular hypertension

 Acta Ophthalmologica
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
 82 2016
Topical delivery of a Rho-kinase inhibitor to the cornea via mucoadhesive film European Journal of Pharmaceutical Sciences
  • Medicine: Pharmacy and materia medica
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 8 2016
Fasudil, a Rho-Associated Protein Kinase Inhibitor, Attenuates Traumatic Retinal Nerve Injury in Rabbits Journal of Molecular Neuroscience
  • Science: Biology (General)
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
 9 2016
Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia Investigative Opthalmology & Visual Science 45 2016
Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms Investigative Opthalmology & Visual Science 105 2016
Citations
Title Journal Journal Categories Citations Publication Date
Recent advances in the development of Rho kinase inhibitors (2015–2021)

 Medicinal Research Reviews
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 1 2023
Intravitreal fasudil monotherapy for treatment of refractory diabetic macular edema: A prospective interventional case series Journal Français d'Ophtalmologie
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
 2023
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives Journal of Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
 6 2023
The evolving therapeutic landscape of diabetic retinopathy Expert Opinion on Biological Therapy
  • Technology: Chemical technology: Biotechnology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General): Medical technology
  • Medicine: Medicine (General)
 2 2023
ROCK Inhibitors as an Alternative Therapy for Corneal Grafting: A Systematic Review Journal of Ocular Pharmacology and Therapeutics
  • Medicine: Ophthalmology
  • Medicine: Therapeutics. Pharmacology
  • Medicine
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 1 2023
Citations Analysis
Category Category Repetition
Medicine: Ophthalmology7
Medicine: Medicine (General)6
Medicine: Therapeutics. Pharmacology5
Science: Biology (General): Cytology4
Science: Chemistry3
Science: Biology (General): Genetics3
Medicine: Public aspects of medicine: Toxicology. Poisons3
Medicine2
Science: Chemistry: Analytical chemistry2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
Technology: Chemical technology1
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Science: Biology (General)1
Science: Chemistry: Organic chemistry: Biochemistry1
Technology: Chemical technology: Biotechnology1
Medicine: Medicine (General): Medical technology1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry1
The category Medicine: Ophthalmology 7 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial and was published in 2018. The most recent citation comes from a 2023 study titled ROCK Inhibitors as an Alternative Therapy for Corneal Grafting: A Systematic Review. This article reached its peak citation in 2023, with 5 citations. It has been cited in 18 different journals, 22% of which are open access. Among related journals, the Journal of Medicinal Chemistry cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year